BioGaia AB (publ) (LON:0GTN)
128.15
-0.04 (-0.03%)
At close: Feb 21, 2025
BioGaia AB Revenue
In the year 2024, BioGaia AB had annual revenue of 1.42B SEK with 9.73% growth. BioGaia AB had revenue of 364.83M in the quarter ending December 31, 2024, with 22.52% growth.
Revenue
1.42B SEK
Revenue Growth
+9.73%
P/S Ratio
n/a
Revenue / Employee
6.32M SEK
Employees
225
Market Cap
954.89M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.42B | 126.21M | 9.73% |
Dec 31, 2023 | 1.30B | 192.55M | 17.44% |
Dec 31, 2022 | 1.10B | 318.85M | 40.61% |
Dec 31, 2021 | 785.11M | 38.03M | 5.09% |
Dec 31, 2020 | 747.08M | -21.27M | -2.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
BP p.l.c. | 149.68B |
British American Tobacco p.l.c. | 25.87B |